Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge
- 13 July 2005
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 131 (9) , 559-567
Abstract
A narrow therapeutic index is a characteristic feature of cytotoxic agents. Some of these agents are almost entirely eliminated renally in unchanged active form. As a consequence, assessment of the individual glomerular filtration rate (GFR) may help to predict the pharmacokinetic behaviour of cytotoxic agents in plasma more precisely. In addition, GFR-adapted individualization of cancer chemotherapy may have an enormous impact on the severity of side effects. Several methods are available to determine GFR or creatinine clearance (CrCl). GFR-measurement based on experimental methods with radiolabelled isotopes, contrast media or inulin helps to reflect the real situation very closely. In addition, 24-h urine collection is a convenient and feasible method to measure creatinine clearance. Finally, several mathematical equations exist to estimate GFR or CrCl based on serum creatinine and other parameters. Only a few of these equations have been developed in oncologic patients. However, some of these equations are routinely used in clinical practice, because they allow a rapid estimation of GFR. Based on the fact that clinically relevant differences have been assessed between calculated values and the real situation, mathematical calculation of GFR or CrCl does not seem to be appropriate to assess individual renal function precisely enough over a broad range of individual GFR or CrCl. Whether the measurement of low-molecular-weight proteins, such as cystatin C and ß-trace protein, may help to reflect the real situation more precisely is a matter of controversial debate.Keywords
This publication has 57 references indexed in Scilit:
- Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patientsAnnals of Oncology, 2004
- Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumoursAnnals of Oncology, 2003
- Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomasHistopathology, 1995
- Comparison of methods of assessment of renal function in patients with cancer treatedwith cisplatin, carboplatin or methotrexateAustralian and New Zealand Journal of Medicine, 1990
- COMPARATIVE EVALUATION OF UROGRAPHIC CONTRAST MEDIA, INULIN, AND 99mTc-DTPA CLEARANCE METHODS FOR DETERMINATION OF GLOMERULAR FILTRATION RATE IN CLINICAL TRANSPLANTATIONTransplantation, 1989
- Use of Serum Creatinine Concentrations to Determine Renal Function1Clinical Pharmacokinetics, 1979
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- COMPUTER-ASSISTED PRESCRIBING OF KANAMYCIN FOR PATIENTS WITH RENAL INSUFFICIENCYThe Lancet, 1972
- ESTIMATION OF CREATININE CLEARANCE WHEN URINE CANNOT BE COLLECTEDThe Lancet, 1971
- Micropuncture Study of Inulin Absorption in the Rat KidneyScience, 1965